The pattern suggests these drugs may work as prevention rather than treatment
Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, et al
Blood Pressure Monitoring Height Weight Body Mass Index (BMI) Observed Effects and Awareness Based on clinical research and reviews, GLP-1 receptor agonist: Help reduce A1C with improved glycaemic control in adults with type 2 diabetes 22 , 23
When to increase your dose Signs its time to move up: No appetite suppression after 4-6 weeks at current dose Weight loss has completely stalled for 3+ weeks Blood sugar markers havent improved Youre tolerating the current dose with zero side effects (some effect means the medication is active) For a visual breakdown of how tirzepatide microdosing compares to standard protocols, see our microdosing tirzepatide dosage chart
The table below highlights symptoms that are usually mild and those that may require medical advice
Tesamorelin for HIV-associated lipodystrophy